UNSPSC 51452402: Diethylcarbamazine

This classification denotes an antihelminthic agent with the molecular formula C10H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V867Q8X3ZD, chemically known as 4-methyl-n,n-bis(4-methylpiperazin-2-yl)-piperazine-1-carboxamide but generally known as diethylcarbamazine, which bears US NIH Compound Identifier 3052. European Medicines Agency schedules Diethylcarbamazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07111MIG. The term DIETHYLCARBAMAZINE is an International Non-Proprietary Name.

UNSPSC 51452402 Diethylcarbamazine is a Commodity code that in practice covers pharmaceutical products acquired by state and local health agencies, though recent solicitations tagged to this code show minimal activity directly aligned with the nominal scope. The Illinois Department of Public Health and Seminole County, Florida have posted procurement activity under or near this code classification, but the opportunities actually sourced antibiotics (Doxycycline Hyclate, Ciprofloxacin Hydrochloride) and overdose-reversal medications (Naloxone) alongside drug deactivation systems rather than the antiparasitic agent the code nominally identifies. State health departments and county public health or community health agencies drive demand under this code family, typically purchasing through cooperative purchasing vehicles such as the MMCAP Infuse consortium and through competitive sealed-bid processes to stock emergency supplies, disease-control inventories, and harm-reduction programs.

Recent activity appears concentrated in Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, for $2,999,999.11 over three years (12-month initial term plus two renewal options) to supply Doxycycline Hyclate and Ciprofloxacin Hydrochloride in bulk tablets; the award followed an Invitation for Bid process. Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building, with a response deadline of July 26, 2023. Both procurements emphasize fixed-fee pricing, electronic bid submission, and multi-year terms with renewal options. The code shows limited recent state and local solicitation volume; code-level activity may be sparse or misclassified in source systems.